Vimal Mehta - CEO and President, Director, 10%+ Owner at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director, 10%+ Owner
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Vimal Mehta - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 7,685,501 $9.86 M $1.28 Jun 14, 2024 By BioXcel LLC
Common Stock 47,539 $61 K $1.28 Jun 17, 2024 Direct
Restricted Stock Units 38,500 $49.4 K $1.28 Jun 15, 2024 Direct Common Stock
Common Stock 2,000 $2.57 K $1.28 Jun 14, 2024 By spouse
Call Options (obligation to sell) 120 Jun 4, 2024 By BioXcel LLC Common Stock

Transactions reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership